思源电气：接受华泰证券资管等投资者调研

Group 1 - Company announced that on October 23, 2025, from 15:00 to 16:00, it will accept investor research from Huatai Securities Asset Management and others, with the market strategy director Li Gang participating in the reception and answering investor questions [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth $80 billion this year, indicating a hot secondary market for biomedicine, while the primary market is experiencing a fundraising slowdown [1]